US Stock MarketDetailed Quotes

PHVS Pharvaris

Watchlist
  • 15.480
  • +0.230+1.51%
Close Mar 26 16:00 ET
  • 15.740
  • +0.260+1.68%
Pre 05:30 ET
839.53MMarket Cap-5.54P/E (TTM)

About Pharvaris Company

Pharvaris NV is a clinical-stage company, which engages in bringing oral bradykinin B2-receptor antagonists to patients. It focuses on the development and commercialization of innovative therapies for rare diseases focused on angioedema and other bradykinin-mediated diseases. The company was founded by Luc Dochez, Jens Schneider-Mergener, Berndt A. E. Modig, Jochen Knolle, Johannes Gerardus Christiaan Petrus Schikan, and Anne Lesage on September 30, 2015 and is headquartered in Leiden, the Netherlands.

Company Profile

SymbolPHVS
Company NamePharvaris
Listing DateFeb 5, 2021
Issue Price20.00
Founded2015
CEOMr. Berndt Modig
MarketNASDAQ
Employees82
Fiscal Year Ends12-31
AddressEmmy Noetherweg 2
CityLeiden
ProvinceZuid-Holland
CountryNetherlands (the)
Zip Code2333 BK
Phone31-71-203-64-10
Websitehttp://www.pharvaris.com

Company Executives

  • Name
  • Position
  • Salary
  • Berndt Modig
  • Chief Executive Officer and Executive Director
  • 935.28K
  • Joan Schmidt
  • Chief Legal Officer
  • --
  • Annick Deschoolmeester
  • Chief Human Resources Officer
  • --
  • Dr. Wim Souverijns, PhD
  • Chief Community Engagement and Commercial Officer
  • --
  • Dr. Stefan Abele, PhD
  • Chief Technical Operations Officer
  • --
  • Dr. Peng Lu, M.D.,PhD
  • Chief Medical Officer
  • --
  • Dr. Morgan Conn, PhD
  • Chief Business Officer
  • --
  • Dr. Anne Lesage, PhD
  • Chief Early Development Officer
  • --
  • Anna Nijdam, M.Sc.
  • Head of Strategic Finance and Principal Accounting Officer
  • --
  • Viviane Monges
  • Independent Director
  • 62.50K
  • Hans Schikan, Pharm.D.
  • Independent Director
  • 61.00K
  • Dr. Robert Glassman, M.D.
  • Independent Director
  • 50.50K
  • Dr. Elisabeth Bjork, M.D.,PhD
  • Independent Director
  • 45.00K
  • Dr. David P. Meeker,M.D.
  • Independent Director
  • 94.00K

Market Insights

U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
The9 Ltd
NCTY
13.1500
BIT Mining
BTCM
1.870
FRMO CORP
FRMO
8.505
4
Digihost Technology
DGHI
1.320
5
Abits
ABTS
3.200
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.